Recommendations
| ShowHide Related Items >><< - 01/21/21
- Facebook: Trump's access to remain suspended 'indefinitely'
- 01/21/21
- Facebook referrering former President Trump's suspension to Oversight Board
- 01/11/21
- Facebook to remove content containing phrase 'stop the steal'
- 01/11/21
- Airbnb says its PAC will 'withhold support' from those who opposed certification
- 06:30 Today Oppenheimer
- Facebook price target raised to $345 from $300 at Oppenheimer
- 06:20 Today Credit Suisse
- Facebook price target lowered to $325 from $330 at Credit Suisse
- 06:10 Today JPMorgan
- Facebook shares 'compelling' into Q4 results, says JPMorgan
- 01/21/21
- Fly Intel: Top five analyst initiations
- 10/29/20
- Facebook sees Q4 ad revenue growth rate higher than Q3
- 10/29/20
- Facebook reports Q3 EPS $2.71, consensus $1.91
- 10/29/20
- Notable companies reporting after market close
- 07/30/20
- Facebook reports Q2 EPS $1.80, consensus $1.39
- 06:09 Today
- Facebook memo told employees to prioritize privacy, OneZero reports
- 01/21/21
- Apple's first headset to focus on virtual reality, Bloomberg reports
- 01/20/21
- Facebook rival MeWe adds 2.5M privacy-seeking users in a week, USA Today says
- 01/19/21
- Facebook has no plans to lift Trump's account suspension, NBC News says
- 01/21/21
- Snap initiation, PayPal upgrade among today's top calls on Wall Street
- 01/20/21
- #SocialStocks: Facebook could be in focus under new administration
- 01/19/21
- Fly Insider: REV Group, Neurocrine Bio among week's notable insider trades
- 01/19/21
- Facebook upgrade, Roku initiation among today's top calls on Wall Street
- 01/15/21
- Facebook call volume above normal and directionally bullish
- 12/21/20
- Facebook call buyer realizes 33% same-day gains
- 12/10/20
- Unusually active option classes on open December 10th
- 12/07/20
- Facebook call volume above normal and directionally bullish
|
Hot Stocks
| ShowHide Related Items >><< - $202.26 /
+0.915 (+0.45%) - 01/21/21
- AbCellera-discovered antibody prevented COVID-19 in nursing homes, reduced risks
- 01/21/21
- Eli Lilly: LY-CoV555 prevented Covid-19 at nursing homes in Blaze-2 trial
- 01/19/21
- Eli Lilly, Merus collaborate for novel T-cell re-directing bispecific antibodies
- 01/15/21
- Eli Lilly reports $30M limited partner investment in Unseen Capital Health Fund
PRVL Prevail Therapeutics - 12/15/20
- Eli Lilly to acquire Prevail Therapeutics for up to $26.50 per share in cash
- 12/11/20
- Prevail Therapeutics doses first patient in Phase 1/2 PROCLAIM trial
- 11/30/20
- Prevail Therapeutics receives EC orphan designation for PR006
- 11/13/20
- Prevail expects to initiate enrollment in Phase 1/2 PROCLAIM trial in Q4
- $202.26 /
+0.915 (+0.45%) - 01/20/21 Citi
- Citi opens 'positive Catalyst Watch' on Eli Lilly into Alzheimer's data
- 01/19/21 Roth Capital
- Merus price target raised to $32 from $19 at Roth Capital
- 01/19/21
- Fly Intel: Top five analyst upgrades
- 01/19/21 Mizuho
- Eli Lilly upgraded to Buy from Neutral at Mizuho
PRVL Prevail Therapeutics - 12/23/20 Wedbush
- Prevail Therapeutics downgraded to Neutral from Outperform at Wedbush
- 12/16/20 Stifel
- Prevail Therapeutics downgraded to Hold from Buy at Stifel
- 12/16/20 Citi
- Prevail Therapeutics downgraded to Neutral from Buy at Citi
- 12/15/20 Cowen
- Prevail Therapeutics downgraded to Market Perform from Outperform at Cowen
- $202.26 /
+0.915 (+0.45%) - 12/15/20
- Eli Lilly sees FY21 EPS $7.75-$8.40, consensus $8.07
- 12/15/20
- Eli Lilly raises FY20 EPS view to $7.45-$7.65 from $7.20-$7.40, consensus $7.32
- 12/02/20
- Eli Lilly says updated purchase of LY-CoV555 to boost FY20 EPS view by 25c
- 10/27/20
- Eli Lilly backs FY20 adj. EPS view $7.20-$7.40, consensus $7.28
PRVL Prevail Therapeutics - 11/13/20
- Prevail Therapeutics reports Q3 EPS (55c), consensus (65c)
- 08/11/20
- Prevail Therapeutics reports Q2 EPS (66c), consensus (59c)
- $202.26 /
+0.915 (+0.45%) - 12/30/20
- Fresenius to administer Lilly, Regeneron COVID antibody drugs, Reuters says
- 12/23/20
- Judge rules against White House drug pricing rule, Reuters says
- 11/23/20
- EU seeks easier access to generic medicines, Reuters says
- 11/20/20
- Trump to release new rules aimed at lowering drug prices, WSJ reports
- $202.26 /
+0.915 (+0.45%) - 01/21/21
- Fly Intel: Wall Street's top stories for Thursday
- 01/21/21
- Fly Intel: Wall Street's top stories at midday
- 01/11/21
- Fly Intel: Wall Street's top stories for Monday
- 01/11/21
- Fly Intel: Wall Street's top stories at midday
PRVL Prevail Therapeutics - 12/15/20
- Fly Intel: Wall Street's top stories for Tuesday
- 12/15/20
- Fly Intel: Wall Street's top stories at midday
- 12/15/20
- Fly Intel: Pre-market Movers
- 10/08/20
- Fly Intel: After-Hours Movers
- $202.26 /
+0.915 (+0.45%) - 01/15/21
- Eli Lilly call volume above normal and directionally bullish
- 01/13/21
- Early notable gainers among liquid option names on January 13th
- 01/11/21
- Early notable gainers among liquid option names on January 11th
- 12/09/20
- Early notable gainers among liquid option names on December 9th
|
Options
| ShowHide Related Items >><< - 01/21/21
- Ford sees 2020 underfunded status for pension of about $6.7B
- 01/21/21
- Ford to replace Takata airbag inflators in certain models at cost of $610M
- 01/19/21
- EU passenger car registrations down 3.3% in December
- 01/11/21
- Ford to stop manufacturing in Brazil, sees pre-tax special item charges of $4.1B
- 01/21/21
- Intel announces 5% increase to quarterly cash dividend
- 01/21/21
- Intel up 7% after early release of Q4 results
- 01/17/21
- Fly Intel: Top five weekend stock stories
- 01/13/21
- Dan Loeb says Intel CEO Bob Swan did 'right thing' to step aside
- 01/21/21
- VirnetX submits agreed BOC, prejudgement interest of $75.7M in Apple suit
- 01/19/21
- Netflix says past year 'testament' to company's approach
- 01/17/21
- Fly Intel: Top five weekend stock stories
- 01/15/21
- VirnetX says court affirms jury award of $502.8M against Apple
- 01/21/21
- Zynga up 2% as TMT Finance speculates on takeover potential
- 11/01/20
- Fly Intel: Top five weekend stock stories
- 09/23/20
- Zynga Launches Harry Potter: Puzzles & Spells worldwide
- 08/05/20
- Zynga to acquire 80% of Rollic for $168M in cash
- 05:31 Today JPMorgan
- Ford upgraded to Overweight from Neutral at JPMorgan
- 01/20/21 Deutsche Bank
- Ford price target raised to $11 from $9 at Deutsche Bank
- 01/20/21 Deutsche Bank
- Ford named 'Catalyst Call: Buy Idea' at Deutsche Bank
- 01/05/21 Benchmark
- GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
- 08:43 Today Morgan Stanley
- Intel price target raised to $72 after 'very strong quarter' at Morgan Stanley
- 07:55 Today Roth Capital
- Intel price target raised to $60 from $50 at Roth Capital
- 07:50 Today Northland
- Intel price target raised to $57 from $46 at Northland
- 07:37 Today BMO Capital
- Intel price target raised to $75 from $70 at BMO Capital
- 07:45 Today Cowen
- Apple price target raised to $153 from $133 at Cowen
- 01/21/21 DA Davidson
- Apple's well positioned with first lineup of 5G phones, says DA Davidson
- 01/21/21 Evercore ISI
- Facebook price target raised to $355 from $320 at Evercore ISI
- 01/21/21 Cowen
- Apple EV opportunity may be in partnership, says Cowen
- 12/22/20 Morgan Stanley
- Zynga price target raised to $12 from $11 at Morgan Stanley
- 12/16/20
- Fly Intel: Top five analyst upgrades
- 12/16/20 JPMorgan
- Zynga upgraded to Overweight from Neutral at JPMorgan
- 12/15/20 Wells Fargo
- Zynga upgraded to Overweight after 'overdone' post-Q3 pullback at Wells Fargo
- 10/28/20
- Ford sees temporarily lower F-150 wholesale shipments in Q4
- 10/28/20
- Ford reports Q3 adjusted EBIT $3.6B
- 10/28/20
- Ford reports Q3 adjusted EPS 65c, consensus 16c
- 10/28/20
- Notable companies reporting after market close
- 01/21/21
- Intel sees Q1 EPS $1.10, consensus 93c
- 01/21/21
- Intel reports Q4 EPS $1.52, consensus $1.10
- 01/21/21
- Notable companies reporting after market close
- 01/13/21
- Intel sees Q4 revenue and EPS to exceed prior guidance
- 10/29/20
- Apple says Q4 results were ahead of expectations
- 10/29/20
- Apple reports Q4 Services revenue $14.55B vs. $12.51B last year
- 10/29/20
- Apple reports Q4 iPhone revenue $24.44B vs. $33.36B last year
- 10/29/20
- Apple reports Q4 EPS 73c, consensus 70c
- 11/04/20
- Zynga sees Q4 bookings of $670M,consensus $653.1M
- 11/04/20
- Zynga reports Q3 EPS (11c), consensus 9c
- 11/04/20
- Notable companies reporting after market close
- 08/05/20
- Zynga cuts FY20 adjusted EBITDA view to $85M from $300M
|
On The Fly
|
Check out this morning's… ShowHide Related Items >><< ADMP Adamis Pharmaceuticals - 01/21/21
- Adamis announces SYMJEPI, epinephrine injection products at Walgreens
- 01/20/21
- Adamis Pharmaceuticals submits Tempol IND application to FDA
- 12/01/20
- Adamis Pharmaceuticals intends to address all deficiencies in ZIMHI CRL
- 11/16/20
- Adamis plunges after Complete Response Letter from FDA for ZIMHI application
- 01/21/21
- Conformis, Sites Medical announce non-exclusive development and supply agreement
- 12/17/20
- Conformis announces U.S. commercial launch of new Cordera Match Hip System
- 09/29/20
- Conformis announces 510(k) clearance for Cordera Hip System
- 08/20/20
- Conformis achieves second milestone under development, license agreements
- 06:05 Today
- Regions Financial reports Q4 Common Equity Tier 1 ratio 9.8% vs. 9.7% last year
- 06:02 Today
- Regions Financial reports Q4 net interest margin 3.13% vs. 3.39% a year ago
- 12/08/20
- Regions Financial announces COO John Owen to retire in 2021
- 10/20/20
- Regions Financial reports Q3 net interest margin 3.13% vs. 3.44% a year ago
- 07:37 Today
- Ally Financial reports Q4 net interest margin 2.90%, up 26 bps y/y
- 01/12/21
- Ally Financial announces $1.6B share repurchase plan, declares dividend of 19c
- 12/08/20
- Ally Financial: Core trends 'look really strong' across the bank
- 12/08/20
- Ally Financial sees mid-teens returns over next 1-2 years
- 06:43 Today
- First Horizon CEO says 'executing well on our merger of equals with IBERIABANK'
- 06:42 Today
- First Horizon raises cost savings from IBERIABANK merger to $200M from $170M
- 06:40 Today
- First Horizon reports Q4 ROCE of 12.53%; ROTCE of 16.73%; Adj. ROTCE of 18.18%
- 12/28/20
- First Horizon announces results of its 2020 company-run stress test
- 06:59 Today
- Schlumberger sees 'clear path' to double-digit margins in North America in 2021
- 06:55 Today
- Schlumberger sees FY21 capital investment $1.5B-$1.7B
- 06:52 Today
- Schlumberger CEO says 'concluded the year posting very strong fourth-quarter'
- 06:50 Today
- Schlumberger reports Q4 cash flow from operations $878M, free cash flow $554M
HBAN Huntington Bancshares - 07:22 Today
- Huntington Bancshares sees FY21 net interest income flat to modestly higher
- 12/14/20
- TCF Financial to merge into Huntington Bancshares in to all-stock deal
- 11/30/20
- Huntington Bancshares to upgrade entire ATM network, replace 400 machines by YE
- 11/22/20
- Fly Intel: Top five weekend stock stories
- 01/21/21
- IBM down 6.5% at $123.24 after Q4 earnings, conference call outlook
- 01/21/21
- IBM sees FY21 'revenue growth based on current spot rates'
- 01/21/21
- IBM NewCo CEO Martin Schroeter says company has 'tremendous potential'
- 01/21/21
- IBM CFO says optimizing NewCo to have a 'leaner' operating model
- $143.94 /
-0.635 (-0.44%) - 01/21/21
- PPG says demand continues to improve in many of its end-use markets
- 01/11/21
- PPG appoints Bhaskar Ramachandran as CIO
- 01/11/21
- PPG reaches definitive agreement to acquire Worwag
- 01/08/21
- PPG to acquire VersaFlex Family of Companies
- 01/21/21
- Senseonics Holder Masters reports 5.89% active stake
- 01/19/21
- Senseonics announces positive coverage decision for Eversense CGM
- 10/05/20
- Senseonics submits PMA application for 180-Day Eversense System to the FDA
- 08/10/20
- Senseonics to partner with Ascensia Diabetes Care
- 01/21/21
- Intel announces 5% increase to quarterly cash dividend
- 01/21/21
- Intel up 7% after early release of Q4 results
- 01/17/21
- Fly Intel: Top five weekend stock stories
- 01/13/21
- Dan Loeb says Intel CEO Bob Swan did 'right thing' to step aside
ADMP Adamis Pharmaceuticals - 11/17/20
- Adamis Pharmaceuticals cut to Hold at Maxim after Zimhi CRL from FDA
- 11/16/20 Maxim
- Adamis Pharmaceuticals downgraded to Hold from Buy at Maxim
- 05/13/20 Maxim
- Adamis Pharmaceuticals upgraded to Buy from Hold at Maxim
- 05/13/20 Maxim
- Adamis Pharmaceuticals upgraded to Buy from Hold at Maxim
- 01/15/21 Compass Point
- Regions Financial upgraded to Buy from Neutral at Compass Point
- 01/12/21 UBS
- UBS downgrades Citizens on revenue headwinds, Wells new top pick
- 01/07/21 Keefe Bruyette
- Regions Financial upgraded to Outperform from Market Perform at Keefe Bruyette
- 01/07/21 Baird
- Regions Financial downgraded to Neutral from Outperform at Baird
- 01/19/21 JPMorgan
- Ally Financial price target raised to $47 from $32 at JPMorgan
- 01/13/21 Janney Montgomery Scott
- Ally Financial price target raised to $45 from $40 at Janney Montgomery Scott
- 01/13/21 Credit Suisse
- Ally Financial price target raised to $42 from $34 at Credit Suisse
- 01/13/21 Citi
- Ally Financial price target raised to $45 from $33 at Citi
- 10/08/20 Jefferies
- First Horizon upgraded to Buy from Hold at Jefferies
- 09/22/20 Raymond James
- First Horizon upgraded to Strong Buy from Outperform at Raymond James
- 08/20/20 Goldman Sachs
- First Horizon reinstated with a Buy at Goldman Sachs
- 08/17/20 Morgan Stanley
- First Horizon resumed with an Equal Weight at Morgan Stanley
- 12/18/20 JPMorgan
- Schlumberger price target raised to $21 from $19 at JPMorgan
- 12/15/20 Citi
- Schlumberger price target raised to $30 from $25 at Citi
- 12/10/20 HSBC
- Schlumberger downgraded to Reduce from Hold at HSBC
- 11/30/20 Susquehanna
- Susquehanna raises targets across Oilfield Services on cyclical rebound
HBAN Huntington Bancshares - 01/13/21 Piper Sandler
- PNC Financial downgraded to Neutral from Overweight at Piper Sandler
- 01/06/21 Wedbush
- Huntington Bancshares added to Best Ideas List at Wedbush
- 01/06/21 Deutsche Bank
- Huntington Bancshares price target raised to $14 from $10.50 at Deutsche Bank
- 01/05/21 Piper Sandler
- TCF Financial upgraded to Overweight from Neutral at Piper Sandler
- 07:01 Today Morgan Stanley
- IBM miss in software elevates concerns, says Morgan Stanley
- 10/20/20 Morgan Stanley
- Morgan Stanley continues to view IBM as 'a 2022 stock'
- 10/20/20 Citi
- IBM is 'getting even more complex,' says Citi
- 10/20/20 BMO Capital
- IBM price target lowered to $138 from $140 at BMO Capital
- $143.94 /
-0.635 (-0.44%) - 01/20/21 Citi
- Citi adds PPG to US Focus List, removes FMC
- 01/14/21 Berenberg
- PPG upgraded to Buy with $165 price target at Berenberg
- 01/14/21 Berenberg
- PPG upgraded to Buy from Hold at Berenberg
- 12/01/20 Deutsche Bank
- PPG price target raised to $165 from $155 at Deutsche Bank
- 01/20/21 BTIG
- BTIG cuts Senseonics to Neutral, sees no fundamental reason for rapid rise
- 01/20/21 BTIG
- Senseonics downgraded to Neutral from Buy at BTIG
- 01/20/21 Craig-Hallum
- Senseonics downgraded to Sell at Craig-Hallum
- 01/20/21 Craig-Hallum
- Senseonics downgraded to Sell from Hold at Craig-Hallum
- 08:43 Today Morgan Stanley
- Intel price target raised to $72 after 'very strong quarter' at Morgan Stanley
- 07:55 Today Roth Capital
- Intel price target raised to $60 from $50 at Roth Capital
- 07:50 Today Northland
- Intel price target raised to $57 from $46 at Northland
- 07:37 Today BMO Capital
- Intel price target raised to $75 from $70 at BMO Capital
- 11/04/20
- Conformis reports Q3 EPS (9c), consensus (12c)
- 10/06/20
- Conformis reports preliminary Q3 revenue $16.1M, consensus $13.02M
- 08/05/20
- Conformis reports Q2 EPS (3c), consensus (10c)
- 06:01 Today
- Regions Financial reports Q4 EPS 61c, consensus 42c
- 01/21/21
- Notable companies reporting before tomorrow's open
- 01/21/21
- Notable companies reporting before tomorrow's open
- 10/20/20
- Regions Financial reports Q3 EPS 52c, consensus 33c
- 07:31 Today
- Ally Financial reports Q4 adjusted EPS $1.60, consensus $1.05
- 01/21/21
- Notable companies reporting before tomorrow's open
- 01/21/21
- Notable companies reporting before tomorrow's open
- 10/16/20
- Ally Financial reports Q3 adjusted EPS $1.25, consensus 68c
- 06:38 Today
- First Horizon reports Q4 adjusted EPS 46c, consensus 33c
- 06:30 Today
- First Horizon reports Q4 adjusted EPS 46c, consensus 33c
- 01/21/21
- Notable companies reporting before tomorrow's open
- 01/21/21
- Notable companies reporting before tomorrow's open
- 06:50 Today
- Schlumberger reports Q4 adjusted EPS 22c, consensus 17c
- 01/21/21
- Notable companies reporting before tomorrow's open
- 01/21/21
- Notable companies reporting before tomorrow's open
- 10/16/20
- Schlumberger reports Q3 adjusted EPS 16c, consensus 12c
HBAN Huntington Bancshares - 07:04 Today
- Huntington Bancshares reports Q4 EPS 27c, consensus 29c
- 07:02 Today
- Huntington Bancshares sees FY21 revenue up about 1%-3%, consensus $5.89B
- 07:01 Today
- Huntington Bancshares reports Q4 EPS 27c, consensus 29c
- 01/21/21
- Notable companies reporting before tomorrow's open
- 01/21/21
- IBM reports Q4 Cloud & Cognitive Software revenue $6.8B, down 4.5%
- 01/21/21
- IBM reports Q4 adjusted EPS $2.07, consensus $1.79
- 01/21/21
- Notable companies reporting after market close
- 10/19/20
- IBM reports Q3 Cloud & Cognitive Software revenue $5.6B, up 7%
- $143.94 /
-0.635 (-0.44%) - 07:10 Today
- PPG sees Q1 adjusted EPS $1.55-$1.61, consensus $1.89
- 01/21/21
- PPG reports Q4 EPS $1.59, consensus $1.58
- 01/21/21
- Notable companies reporting after market close
- 10/19/20
- PPG sees Q4 adjusted EPS $1.50-$1.57, consensus $1.44
- 12/23/20
- Senseonics sees FY21 revenue $12M-$15M, consensus $12.7M
- 12/23/20
- Senseonics sees Q4 revenue $3.5M, consensus $2.49M
- 11/09/20
- Senseonics reports Q3 EPS (10c), consensus (6c)
- 08/10/20
- Senseonics reports Q2 EPS (3c), consensus (9c)
- 01/21/21
- Intel sees Q1 EPS $1.10, consensus 93c
- 01/21/21
- Intel reports Q4 EPS $1.52, consensus $1.10
- 01/21/21
- Notable companies reporting after market close
- 01/13/21
- Intel sees Q4 revenue and EPS to exceed prior guidance
|
Recommendations
|
Jefferies analyst Janine… ShowHide Related Items >><< - 01/21/21
- American Eagle targeting 600-700 AE stores in U.S. and Canada
- 01/21/21
- American Eagle announces long term growth targets
- 12/03/20
- American Eagle reinstates 13.75c per share quarterly dividend
- 11/24/20
- American Eagle says dividend suspension remains in place
- 07:47 Today B. Riley Securities
- American Eagle price target raised to $30 from $28 at B. Riley Securities
- 07:45 Today BMO Capital
- American Eagle price target raised to $26 from $19 at BMO Capital
- 06:43 Today Deutsche Bank
- American Eagle price target raised to $29 from $25 at Deutsche Bank
- 06:25 Today Citi
- American Eagle price target raised to $30 from $21 at Citi
- 01/21/21
- American Eagle sees Q4 revenue down low single digits, consensus $1.31B
- 11/24/20
- American Eagle reports Q3 EPS 35c, consensus 34c
- 11/24/20
- Notable companies reporting after market close
- 09/09/20
- American Eagle reports Q2 adj. EPS (3c), consensus (16c)
- 11/05/20
- American Eagle partners with Disney for holiday collaboration, WWD reports
- 09/03/20
- American Eagle launches Snapchat dance challenge, WWD reports
- 11/24/20
- Fly Intel: After-Hours Movers
- 10/14/20
- Microsoft resumption, Nio upgrade among top calls on Wall Street
- 10/07/20
- Fly Intel: Pre-market Movers
- 07/30/20
- Walmart, Target initiations among today's top calls on Wall Street
- 12/29/20
- American Eagle call volume above normal and directionally bullish
- 11/24/20
- American Eagle options imply 10.4% move in share price post-earnings
- 10/29/20
- American Eagle put volume heavy and directionally bearish
- 10/19/20
- American Eagle put volume heavy and directionally bearish
|